These data indicate that breast cancer, particularly the basal-like subtype, has a high frequency of CNAs and somatic mutations in several HMTs, including amplification of ASH1L, SETDB1, and SMYD3, as well as homozygous deletion of SETDB2. Here, ASH1L is linked to breast carcinoma.